- Home
- INM vs CPHI Comparison
INM vs CPHI Comparison
Compare INM & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- CPHI
- Stock Information
- Founded
- INM 1981
- CPHI N/A
- Country
- INM Canada
- CPHI China
- Employees
- INM N/A
- CPHI 239
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- CPHI Health Care
- Exchange
- INM Nasdaq
- CPHI Nasdaq
- Market Cap
- INM 3.4M
- CPHI 4.0M
- IPO Year
- INM N/A
- CPHI N/A
- Fundamental
- Price
- INM $4.95
- CPHI $0.21
- Analyst Decision
- INM
- CPHI
- Analyst Count
- INM 0
- CPHI 0
- Target Price
- INM N/A
- CPHI N/A
- AVG Volume (30 Days)
- INM 26.6K
- CPHI 1.9M
- Earning Date
- INM 02-11-2025
- CPHI 11-13-2024
- Dividend Yield
- INM N/A
- CPHI N/A
- EPS Growth
- INM N/A
- CPHI N/A
- EPS
- INM N/A
- CPHI N/A
- Revenue
- INM $4,960,506.00
- CPHI $5,544,620.00
- Revenue This Year
- INM N/A
- CPHI N/A
- Revenue Next Year
- INM N/A
- CPHI N/A
- P/E Ratio
- INM N/A
- CPHI N/A
- Revenue Growth
- INM 5.17
- CPHI N/A
- 52 Week Low
- INM $2.42
- CPHI $0.13
- 52 Week High
- INM $15.70
- CPHI $0.60
- Technical
- Relative Strength Index (RSI)
- INM 55.90
- CPHI 49.71
- Support Level
- INM $4.07
- CPHI $0.19
- Resistance Level
- INM $5.41
- CPHI $0.24
- Average True Range (ATR)
- INM 0.39
- CPHI 0.04
- MACD
- INM 0.01
- CPHI -0.00
- Stochastic Oscillator
- INM 67.83
- CPHI 23.53
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.